# Yosemite Fund I

> Yosemite oncology-focused Fund I closed at $263M in 2024. Reported investments include Chai Discovery, Teal Health, Tune Therapeutics and Sage Care. Fund economics and cheque sizes undisclosed; the manager also operates a distinct philanthropic research-grants channel.

## Profile

- **Stage-based planning range:** $100K–$1M
- **Check-size evidence basis:** estimated
- **Founded:** N/A
- **Headquarters:** San Francisco, USA
- **AUM:** N/A
- **Rounds they lead:** N/A
- **Rounds they invest:** N/A

## Links

- [Website](https://yosemite.co/)

## Research sources

- [Founder interview, Fortune, Nov 4 2026](https://fortune.com/2026/11/04/reed-jobs-yosemite-raises-350-million-second-fund-make-cancer-non-lethal/)

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/fund/yosemite-fund-i